PP
PMC

PDT Partners’s PharMerica Corporation PMC Stock Holding History

PDT Partners’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-25,156
Closed -$716K – 1185
2015
Q3 		$716K Buy
+25,156
New +$845K 0.02% 805

Other funds holding PMC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

PDT Partners's PMC Position: Q4 2015 in Review

PDT Partners sold out of PharMerica Corporation (PMC) in Q4 2015, closing a stake of 25,156 shares — an estimated $716K sold.

PDT Partners first reported a position in PMC in Q3 2015 and held it in 1 quarter. The position peaked at $716K in Q3 2015. 195 funds tracked by Wall St. Rank hold PMC as of Q4 2015.

  • PDT Partners reported no remaining PharMerica Corporation position as of Q4 2015 after selling out during the quarter.
  • PDT Partners sold 25,156 PharMerica Corporation shares in Q4 2015, an estimated $716K.
  • PDT Partners first reported a position in PharMerica Corporation in Q3 2015 and held it in 1 quarter.
  • PDT Partners's PharMerica Corporation position peaked at $716K in Q3 2015.
  • 195 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2015.

Based on PDT Partners's 13F filing for Q4 2015, filed 16 Feb 2016.